申请人:Sankyo Company, Limited
公开号:US05843973A1
公开(公告)日:1998-12-01
A thiazolidinone compound represented by general formula (I) or a pharmacoligically acceptable salt thereof, ##STR1## wherein W represents sulfur or oxygen and X represents --N(R.sup.1)--, or alternatively X represents sulfur or oxygen and W represents --N(R.sup.1)--, and R.sup.1 represents hydrogen, alkyl or substituted alkyl; R.sup.2 and R.sup.3 are the same or different from each other, and each represents hydrogen, alkyl, substituted alkyl, aryl, or 5- or 6-membered heteroaryl; R.sup.4 represents hydrogen, alkyl or substituted C.sub.1 -C.sub.4 alkyl; R.sup.5 represents substituted cycloalkyl which may contain nitrogen, provided the substituents include --B--ONO.sub.2 (wherein B represents a single bond or alkylene) as the indispensable member and alkyl groups as optional members; and A represents a single bond or alkylene, has an excellent anti-anginal effect and thus is useful as an angina pectoris remedy or preventive.
一种噻唑烷酮化合物,其通式为(I)或其药学上可接受的盐,##STR1##其中W代表硫或氧,X代表--N(R.sup.1)--,或者X代表硫或氧,W代表--N(R.sup.1)--,R.sup.1代表氢、烷基或取代烷基;R.sup.2和R.sup.3彼此相同或不同,各自代表氢、烷基、取代烷基、芳基或5或6元杂芳基;R.sup.4代表氢、烷基或取代的C.sub.1 -C.sub.4烷基;R.sup.5代表可能含有氮的取代环烷基,其取代基包括作为必需成员的--B--ONO.sub.2(其中B代表单键或亚烷基)以及作为可选成员的烷基;A代表单键或亚烷基,具有优异的抗心绞痛效果,因此可作为心绞痛的治疗或预防药物。